RxDoctor Payments Data

Tonia Nerini, NP

Gerontology · Bevier, MONPI 1790220606

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Amgen accounts for 77.2% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $16,707, 9.3 times the $1,805 reported in 2021. Among gerontology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,889in general payments, 2019–2025

Across 515 payments — averaging $56.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$22K
  • AbbVie$2K
  • Novartis$956
  • Mallinckrodt Hospital Products Inc.$853
  • ANI Pharmaceuticals, Inc.$547
  • GSK$311
  • plus $2K from 17 others

What the payments were for

  • Speaking & faculty fees$17,20060%
  • Travel & lodging$2,84810%
  • Food & beverage$8,70530%
  • Education$1360%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,889 in reported general payments places this provider in the 95th percentile of 175 gerontology providers in Missouri.

See all gerontology providers in Missouri

Medicare billing

Part B allowed, 2024
$3,651
Medicare patients
34
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ActharCorticotropin24$1,599,379
Enbrel SureclickEtanercept34$274,930
Humira(Cf) PenAdalimumab27$199,480
RinvoqUpadacitinib26$169,910
Taltz AutoinjectorIxekizumab21$147,370
Actemra ActpenTocilizumab24$95,447
Cosentyx Sensoready (2 Pens)Secukinumab11$89,360
Humira(Cf)Adalimumab12$81,739
Orencia ClickjectAbatacept14$78,997
Hydroxychloroquine Sulfate372$10,964
Leflunomide92$4,224
Mycophenolate Mofetil48$2,429
MethotrexateMethotrexate Sodium201$2,223
Colchicine48$1,946
Tramadol Hcl63$752

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Mallinckrodt Hospital Products Inc.Acthar$853$1,599,37924 claims
AbbVieRinvoq, Humira(Cf)$2,198$251,64938 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 175 gerontology providers in Missouri.

Other gerontology in Bevier

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →